The study highlights the complexity of healthcare costs for ADRD patients who develop delirium

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

Alzheimer's dementia and related disorders (ADRD) affect more than 5 million people in the United States, and there are no known treatments to stop or prevent their progression. Associated with these diagnoses are costly healthcare bills, which are particularly costly for ADRD patients, who also experience delirium: a preventable mental deterioration. The exact annual health care costs associated with delirium in older hospitalized patients with ADRD had not been examined before a study by researchers at the Brigham and the Marcus Institute, Hebrew SeniorLife. The team conducted a health economic analysis of Medicare costs at 30, 90 and 365 days for 311 patients...

Mehr als 5 Millionen Menschen in den Vereinigten Staaten sind von Alzheimer-Demenz und verwandten Erkrankungen (ADRD) betroffen, und es gibt keine bekannten Behandlungen, um ihr Fortschreiten zu stoppen oder zu verhindern. Verbunden mit diesen Diagnosen sind kostspielige Gesundheitsrechnungen, die besonders kostspielig für ADRD-Patienten sind, die zusätzlich ein Delirium erleben: eine vermeidbare geistige Verschlechterung. Die genauen jährlichen Gesundheitskosten im Zusammenhang mit Delirium bei älteren Krankenhauspatienten mit ADRD waren vor einer Studie von Forschern des Brigham and the Marcus Institute, Hebrew SeniorLife, nicht untersucht worden. Das Team führte eine gesundheitsökonomische Analyse der Medicare-Kosten nach 30, 90 und 365 Tagen für 311 Patienten …
Alzheimer's dementia and related disorders (ADRD) affect more than 5 million people in the United States, and there are no known treatments to stop or prevent their progression. Associated with these diagnoses are costly healthcare bills, which are particularly costly for ADRD patients, who also experience delirium: a preventable mental deterioration. The exact annual health care costs associated with delirium in older hospitalized patients with ADRD had not been examined before a study by researchers at the Brigham and the Marcus Institute, Hebrew SeniorLife. The team conducted a health economic analysis of Medicare costs at 30, 90 and 365 days for 311 patients...

The study highlights the complexity of healthcare costs for ADRD patients who develop delirium

Alzheimer's dementia and related disorders (ADRD) affect more than 5 million people in the United States, and there are no known treatments to stop or prevent their progression. Associated with these diagnoses are costly healthcare bills, which are particularly costly for ADRD patients, who also experience delirium: a preventable mental deterioration. The exact annual health care costs associated with delirium in older hospitalized patients with ADRD had not been examined before a study by researchers at the Brigham and the Marcus Institute, Hebrew SeniorLife.

The team conducted a health economic analysis of Medicare costs at 30, 90 and 365 days for 311 patients with and without ADRD, some of whom developed delirium during their hospital stay. The team found that the average incremental cost for the year of care for an ADRD patient with delirium is $34,828 more than for ADRD patients without delirium; This gap between the prices of ADRD patients with delirium and ADRD patients without delirium also increased over the year. In addition, the study showed that the increased costs of ADRD patients with delirium occurred later in the 365-day period, while the costs of ADRD patients without delirium remained constant over time, and the costs of delirium patients without ADRD increased consistently over time.

“The costs of delirium and severe delirium in ADRD patients are not upfront but rather long-term—like the costs of care and support at home after hospitalization and delirium,” said lead author Tammy Hshieh, MD, MPH, of Brigham's Division of Aging and the Aging Brain Center, Hebrew SeniorLife. “Because delirium is preventable, patients and their families can advocate for nonpharmacologic interventions and general vigilance in clinical care during hospitalization to try to prevent the costly cascade.”

Source:

Brigham and Women's Hospital

Reference:

Hshieh, TT, et al. (2022) One-Year Medicare Costs Associated with Delirium in Elderly Hospitalized Patients With and Without Alzheimer's Dementia and Related Conditions. Alzheimer's & Dementia. doi.org/10.1002/alz.12826.

.